CardioComm Solutions Stock

CardioComm Solutions ROCE

The Return on Capital Employed (ROCE) of CardioComm Solutions (EKG.V) as of Jul 30, 2026 is 105.24 %. In the previous year, Return on Capital Employed (ROCE) was 41.11 % — a change of 155.98% (higher).

ROCE

105.24 %

YoY

155.98%

Last updated:

In 2026, CardioComm Solutions's return on capital employed (ROCE) was 105.24 %, a 155.98% increase from the 41.11 % ROCE in the previous year.

Access this data via the Eulerpool API

CardioComm Solutions Stock analysis

What does CardioComm Solutions do? CardioComm Solutions Inc is a Canadian company specialized in the development and marketing of monitoring and management solutions for EKG data. The company offers innovative products and services aimed at improving the efficiency and quality of EKG monitoring. History: CardioComm Solutions Inc was founded in 1994 by Etienne Grima in Toronto. Since its establishment, the company has developed a variety of products and services that provide easy and effective access to EKG data. Over the years, CardioComm Solutions Inc has received several awards, including the Innovations Award from Canadian Healthcare Technology in 2008. Business model: CardioComm Solutions Inc's business model includes the development and marketing of EKG monitoring solutions for various markets. The company offers products and services for hospitals, clinics, medical facilities, and other healthcare providers. It also provides solutions for consumer and fitness markets. The company has built an extensive network of partners in North America, Europe, and Asia to provide its customers worldwide with quick and easy access to its products and services. Divisions: CardioComm Solutions Inc offers various divisions. An important focus is on the development of EKG monitoring systems for hospitals and medical facilities. These solutions are aimed at improving workflow and patient monitoring efficiency. Another important area is telemedicine. The company offers solutions that allow patients to monitor their EKG data from home and share it with their doctors. This enables more effective monitoring of patients with heart problems, especially in regions with limited access to medical care. In addition, the company also offers solutions for consumer and fitness markets. One of the company's best-known brands is KardiaMobile. KardiaMobile is a portable EKG device held in the hand and connected to a smartphone app that allows for quick and accurate heart rhythm monitoring. The company has also developed a similar device called KardiaBand, which is worn in the form of a wristband. Products: CardioComm Solutions Inc's products include a variety of EKG monitoring solutions tailored to the needs of different markets. One of the well-known solutions is the Global EKG Management System (GEMS). GEMS is a web-based solution that enables reception, display, and access to EKG data from various locations. The company also offers mobile solutions, including KardiaMobile and KardiaBand, as well as solutions for clinical studies and research projects. Additionally, the company provides training and support for its products and services. Conclusion: CardioComm Solutions Inc is an innovative company that offers a wide range of EKG monitoring and management solutions for various markets. The company has built a reputation for quality and reliability and has a strong presence in the global market. With its advanced technology and dedicated professionals, CardioComm Solutions Inc is well-positioned to achieve further growth and success in the coming years. CardioComm Solutions is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling CardioComm Solutions's Return on Capital Employed (ROCE)

CardioComm Solutions's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing CardioComm Solutions's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

CardioComm Solutions's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in CardioComm Solutions’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about CardioComm Solutions stock

Return on Capital Employed (ROCE) of CardioComm Solutions is 105.24 % in 2026.

Access this data via the Eulerpool API

Profitability — CardioComm Solutions

All Key Metrics — CardioComm Solutions